COH34 is a potent and specific poly(ADP-ribose) glycohydrolase (PARG) inhibitor with an IC 50 of 0.37 nM. COH34 binds to the catalytic domain of PARG ( K d =0.547 μM), thereby prolonging PARylation at DNA lesions and trapping DNA repair factors
In Vitro
COH34 efficiently kills PARP inhibitor-resistant cancer cells. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
COH34 induces lethality in cancer cells with DNA repair defects and exhibits antitumor activity in xenograft mouse cancer models . MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Form:Solid
IC50& Target:IC50: 0.37 nM (PARG)
规格
规格或纯度
≥99%
英文名称
COH34
生化机理
COH34 是一种强效的特异性聚(ADP-核糖)糖水解酶(PARG)抑制剂,IC 50 为 0.37 nM。COH34 可与 PARG 的催化结构域结合(K d =0.547 μM),从而延长 PAR 在 DNA 病变处的乙酰化时间,并捕获 DNA 修复因子。